Núñez-Hernández VJ, Vargas-Cerero EA, Sánchez-Madrigal J, Jaramillo E, Martínez-Navarro J, Nava A

Language: Spanish
References: 16
Page: 15-19
PDF size: 211.23 Kb.

ABSTRACT

The decline and/or absence of appetite is also called anorexia. Often people come to the pharmacy looking for weight loss supplements. Just as there are people seeking to lose weight, we have the opposite side, those who seek to gain weight. The exact reason of appetite loss is often unknown, but it may be due to depression, anxiety or symptoms of illness; it commonly occurs in adults, and once disease has been ruled out, dietary supplements can be used. We must know that most dietary supplements are based on an action called antiserotonin, because serotonin is a mediator between the brain centers regulating appetite. It is important to say that many supplements have drugs, and others, vitamins and minerals. Most require prescriptions.

REFERENCES

1. Tébar J, Garaulet M, García M. Regulación del apetito: nuevos conceptos. Rev Esp Obes. 2003; 1 (1): 13-20.

2. Ramos-Ibañez N. Hambre, saciedad y apetito. Su repercusión en el estado nutricional de los individuos. Nutrición clínica. 2002; 5 (4): 296-308.

3. Samya Z, Drury D. Appetite stimulants use in cystic fibrosis. Pediatric Pulmonology. 2008; 43: 209–219.

4. Observatorio de Hidratación y Salud. Hidratación en las personas mayores. Madrid: Anfabra; 2007.

5. Mattes R. Hunger and thirst: issues in measurement and prediction of eating and drinking. Physiol Behav. 2010; 100 (1): 22–32.

6. McKiernan F, Hollis JH, McCabe GP, Mattes RD. Thirst-drinking, hunger-eating; tight coupling? J Am Diet Assoc. 2009; 109 (3): 486-490.

7. Calzada-León R, Altamirano-Bustamante N, Ruiz-Reyes ML. Reguladores neuroendocrinos y gastrointestinales del apetito y la saciedad [Internet]. Bol Med Hosp Infant Mex. 2008 [acceso 27 noviembre 2013]; 65 (6): 468-487.

8. J Salvador, G Frühbeck. Regulación de la ingesta alimentaria: una perspectiva clínica. Endocrinol Nutr. 2005; 52 (8): 404-430.

9. Tucci S. Ghrelina en regulación del apetito y en papel en obesidad y trastornos alimentarios; abordajes terapéuticos. Revisión. Rev Venez Endocrinol Metab. 2008; 6 (2): 15-23.

10. Wren AM, Seal LJ, Cohen MA et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab. 2001; 86: 5992.

11. JE Morley. Orexigenic and anabolic agents. Clin Geriatr Med. 2002; 18: 853-866.

12. Pockels R, Lora E. Uso de estimulantes del apetito en la población infantil. Archivos Dominicanos de Pediatría. 1994; 30 (2): 30-32.

13. Heisler LK, Cowley MA, Tecott LH, Fan W, Low MJ, Smart JL et al. Activation of central melanocortin pathways by fenfluramine. Science. 2002; 297.

14. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 1997; 88: 131-141.

15. Delgado TC. Glutamate and GABA in appetite regulation. Front Endocrinol (Lausanne). 2013; 4: 103.

16. Thomas DR. Guidelines for the Use of Orexigenic Drugs in-long Term. Nutri Clin Pract. 2006; 21: 82.